Quantification of tumour-infiltrating immune cells through deconvolution of DNA methylation data in Ewing sarcomas
Frontiers in Epigenetics and Epigenomics · 2024
DOI: 10.3389/freae.2024.1427399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Epigenetics and Epigenomics, 2024. Verfasst von Sara Patrizi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Onco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ewing Sarcomas (EWS, OMIM # 612219) presents a major challenge in pediatric oncology due to its aggressive nature and poor prognosis, particularly in metastatic cases. Genetic fusions involving the EWSR1 gene and ETS family transcription factors are common in EWS, though other rarer fusions have also been identified. Current standard techniques like immunohistochemistry have failed to fully characterize the immune tumor microenvironment of EWS, hindering insights into tumor development and treatment strategies. Recent efforts apply gene expression datasets to quantify tumor-infiltrating immune cells in EWS. Similar deconvolution techniques can be also applied to DNA methylation (DNAm) arrays, which are much more stable compared to RNA-based methods. This study aims to characterize immune cell infiltration in EWS using DNAm array data. We collected 32 EWS samples from 32 consecutive patients referred to Bambino Gesù Children’s Hospital. DNAm analysis was performed by EPIC arrays; data loading, normalization, deconvolution and survival analysis were then performed in R programming environment. We observed a higher content of dendritic cells and longer overall survival in samples with EWSR1::FLI1 translocation compared to samples with rarer fusions. Moreover, T-memory lymphocytes and monocytes emerged as a significant predictor of overall survival. This study underscores the potential of DNAm arrays in providing robust insights into EWS immune profiles, offering a promising avenue for future research. Further investigations with larger cohorts are warranted to validate these findings and explore additional immune cell types influencing EWS outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Onco-Hematology, Cell Therapy, Gene Therapies and Hemopoietic Transplant, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Pathology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Zitieren
APA
Patrizi, S., Vallese, S., Pedace, L., Nardini, C., Stracuzzi, A., Barresi, S., Giovannoni, I., Abballe, L., Antonacci, C., Russo, I., Di Giannatale, A., Alaggio, R., Locatelli, F., Milano, G. M., & Miele, E. (2024). Quantification of tumour-infiltrating immune cells through deconvolution of DNA methylation data in Ewing sarcomas. Frontiers in Epigenetics and Epigenomics. https://doi.org/10.3389/freae.2024.1427399
Vancouver
Patrizi S, Vallese S, Pedace L, Nardini C, Stracuzzi A, Barresi S, et al. Quantification of tumour-infiltrating immune cells through deconvolution of DNA methylation data in Ewing sarcomas. Frontiers in Epigenetics and Epigenomics. 2024. doi:10.3389/freae.2024.1427399
BibTeX
@article{Patrizi2024,
author = {Patrizi, Sara and Vallese, Silvia and Pedace, Lucia and Nardini, Claudia and Stracuzzi, Alessandra and Barresi, Sabina and Giovannoni, Isabella and Abballe, Luana and Antonacci, Celeste and Russo, Ida and Di Giannatale, Angela and Alaggio, Rita and Locatelli, Franco and Milano, Giuseppe Maria and Miele, Evelina},
title = {Quantification of tumour-infiltrating immune cells through deconvolution of DNA methylation data in Ewing sarcomas},
journal = {Frontiers in Epigenetics and Epigenomics},
year = {2024},
doi = {10.3389/freae.2024.1427399}
}
EUVIMED